Tumor immune microenvironment characterization and response to anti-PD-1 therapy

Tumor immune microenvironment characterization and response to anti-PD-1 therapy

Bibliographic Details
Main Authors:	Mariacarmela Santarpia, Niki Karachaliou
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2015-06-01
Series:	Cancer Biology & Medicine
Online Access:	http://www.cancerbiomed.org/index.php/cocr/article/view/843

Similar Items

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
by: Xianjie Jiang, et al.
Published: (2019-01-01)

Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment
by: So Young Yoo, et al.
Published: (2020-06-01)

Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy
by: Shinya Sakata, et al.
Published: (2021-02-01)

Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy
by: Barbara Wegiel, et al.
Published: (2018-08-01)

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
by: Jiawen Qian, et al.
Published: (2018-10-01)

Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
by: Weimin Lin, et al.
Published: (2018-11-01)

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
by: Mariacarmela Santarpia, et al.
Published: (2020-06-01)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
by: Florent Petitprez, et al.
Published: (2020-05-01)

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
by: Valerie Chew, et al.
Published: (2020-07-01)

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints
by: Niki Karachaliou, et al.
Published: (2015-06-01)

The role of the PD-1 pathway in the tumor microenvironment
by: Juneja, Vikram R
Published: (2017)

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
by: Crescenzo D’Alterio, et al.
Published: (2019-10-01)

Iron Metabolism in the Tumor Microenvironment—Implications for Anti-Cancer Immune Response
by: Alessandro Sacco, et al.
Published: (2021-02-01)

YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment
by: Xiaochen Yang, et al.
Published: (2021-06-01)

Regulation of PD-L1 expression in the tumor microenvironment
by: Ming Yi, et al.
Published: (2021-01-01)

Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer
by: Runsen Jin, et al.
Published: (2020-08-01)

Application of Bionanomaterials in Tumor Immune Microenvironment Therapy
by: Jiawei Wang, et al.
Published: (2021-01-01)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
by: Rachael M. Zemek, et al.
Published: (2020-02-01)

Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients
by: Tuba N. Gide, et al.
Published: (2020-01-01)

Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
by: Allan Scarpitta, et al.
Published: (2021-08-01)

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
by: A. Capasso, et al.
Published: (2019-02-01)

New Progress in the Relationship between Immune Cells, PD-1  in Tumor Microenvironment and the Efficacy of EGFR-TKIs
by: Shiyang YUAN, et al.
Published: (2017-11-01)

Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity
by: Nicole E. Scharping, et al.
Published: (2016-12-01)

Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
by: Tiecheng Wang, et al.
Published: (2021-06-01)

Driving Immune Responses in the Ovarian Tumor Microenvironment
by: Franklin Ning, et al.
Published: (2021-01-01)

Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity
by: Elizabeth R. Sturgill, et al.
Published: (2021-01-01)

Activation of viral defense signaling in cancer
by: Maria Gonzalez-Cao, et al.
Published: (2018-08-01)

Human endogenous retroviruses and cancer
by: María Gonzalez-Cao, et al.
Published: (2016-12-01)

Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
by: Valerie Chew, et al.
Published: (2012-01-01)

Understanding the tumor immune microenvironment (TIME) for effective therapy
by: Binnewies, Mikhail, et al.
Published: (2018)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
by: Xiao-Jun Guo, et al.
Published: (2021-08-01)

Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma
by: Hassan Rahimi Koshkaki, et al.
Published: (2020-09-01)

OA3-1 HIV reservoir dynamics and immune responses after anti-PD-1 therapy
by: E. Scully, et al.
Published: (2017-07-01)

Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy
by: Miles C. Andrews, et al.
Published: (2018-05-01)

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
by: Veronika Weyerer, et al.
Published: (2021-05-01)

Meningiomas and the tumor microenvironment: expression of PD-L1 and expression of PD-L1 and interferon-gamma in the prognosis
by: Gunter Gerson, et al.

Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer
by: Xin Luo, et al.
Published: (2021-06-01)

Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes
by: Tomás Álvaro, et al.
Published: (2010-01-01)

Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
by: Tong Fu, et al.
Published: (2021-06-01)

MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment
by: Douglas D. Fang, et al.
Published: (2019-11-01)

Cannot write session to /tmp/vufind_sessions/sess_3hejiuu4lsl3950efbvbae779v